# Nuclide record lisa-bodei (person). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/people/lisa-bodei/>
  a schema:Person ;
  nuclide:kind "person" ;
  schema:identifier "lisa-bodei" ;
  schema:name "Lisa Bodei"@en ;
  schema:description "An Italian-trained nuclear medicine doctor who helped develop the lutetium-177 dotatate treatment for neuroendocrine tumours and now leads targeted radionuclide therapy at Memorial Sloan Kettering in New York."@en ;
  schema:url <https://nuclide.cc/people/lisa-bodei/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/doctors/lisa-bodei>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC11876735/> ;
  nuclide:tag "neuroendocrine", "PRRT", "clinician" ;
  schema:jobTitle "Attending Physician and Director of Targeted Radionuclide Therapy, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center; Professor of Radiology, Weill Cornell Medical College" ;
  nuclide:related <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/trials/netter-1/>, <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/institutions/mskcc/>, <https://nuclide.cc/isotopes/lu-177/> .